Boltzmann Labs

???Powering Sustainable Process Development with ReBolt Sustainability in chemical and pharmaceutical manufacturing isn’t just a goal — it’s a necessity. At Boltzmann Labs, our AI-powered platform ReBolt is designed to accelerate sustainable process development by harnessing the power of generative chemistry and retrosynthetic analysis. ???How ReBolt drives sustainability: ??Green retrosynthesis: Identifies eco-friendly synthesis routes, reducing hazardous reagents and waste. ??Efficiency without compromise: Optimizes reaction pathways to balance sustainability and process efficiency. As industries push towards net-zero goals, adopting AI-driven tools like ReBolt offers a competitive edge — enabling innovation while minimizing environmental impact. Let’s collaborate to build greener, smarter solutions for process development. Interested in exploring how ReBolt can transform your processes? Let’s connect: [email protected] #SustainableChemistry #GreenManufacturing #AIforSustainability #ReBolt #PharmaInnovation #ChemicalEngineering #CircularEconomy #NetZero #ClimateAction

?? Exciting Announcement! ??? Introducing the Boltzmann AI Discovery Suite – the next frontier in AI-powered drug discovery! ??AI Multi-Agent System – Unlock the power of AI for bioinformatics, medicinal chemistry, synthetic chemistry, and cheminformatics.?? ?Automated Workflows – Streamlining hit identification, lead optimization, and retrosynthesis like never before.?? ?New Look – A fresh, intuitive, and enhanced user experience.? We're revolutionizing the way drug discovery happens. Are you ready for the future of AI-driven innovation? ?? Coming Soon! Stay tuned for updates. ??? #DrugDiscovery #MachineLearning #Biotech #MedChem #Innovation #Automation #PharmaTech #lifesciences #RandD #discovery #research #drugdesign

On the occasion of International Women's Day, we celebrate the women in STEM—scientists, AI engineers, and leaders—who accelerate action ?? , push boundaries, ask bold questions, and help shape the future alongside their peers. Your curiosity, resilience, and brilliance don’t just move science forward—they move us all forward. At Boltzmann Labs, innovation is a team effort, and with 50% of our workforce comprising of women, we know that the best breakthroughs happen when diverse minds collaborate. Here’s to the women working towards shaping innovation into reality. Here’s to you. ??? #AccelerateAction? #WomenInSTEM #IWD2025 #BoltzmannLabs

Exciting Launch Coming Soon!?? We’re thrilled to announce that our launch is just around the corner, and we can’t wait to share what we’ve been working on! This release is all about enhancing the experience for our users with some major updates, including the #MultiAgentSystem for efficient drug discovery & development and Automated Workflows — all wrapped in a sleek, modern interface designed to be more intuitive than ever. Stay tuned for more details – we’re excited for you to experience these updates firsthand! #agenticai #genai #DrugDiscovery, #AIinPharma, #MultiAgentSystem, #AutomatedWorkflows, #PharmaTech, #AIForScience, #ClinicalTrials, #MachineLearning, #BiotechInnovation, #DrugDevelopment, #ArtificialIntelligence, #LifeSciencesTech, #PharmaInnovation #TechInnovation #NewFeatures #Automation #Workflows #UXDesign #aidrugdiscovery #aiforlifesciences #techbio #boltzmannlabs

We’re thrilled to share that Boltzmann Labs has been recognized as one of the Top 5 Startups at #BioAsia2025! ?? At Boltzmann Labs, we’re leveraging cutting-edge AI tools to push the boundaries of computational drug discovery— designing novel therapeutics faster, smarter, and more efficiently. A huge thank you to BioAsia 2025 for this recognition and to our incredible team, partners, and supporters who make this journey possible! This milestone highlights our strong commitment to revolutionizing AI-driven drug discovery and development. Excited for what’s ahead. ?? Debjani Ghosh| nasscom| T-Hub |Society for Innovation & Entrepreneurship -SINE IIT Bombay | Telangana Lifesciences Kolli Sarath | Paritosh Prashar #AI #DrugDiscovery #Biotech #BioAsia2025 #HealthcareInnovation

?? Proud moment for Boltzmann Labs! We’re thrilled to be recognized as one of the Top 5 Startups at #BioAsia2025 — a big win for AI-driven drug discovery and our mission to accelerate treatments for cancer and autoimmune diseases. A huge thank you to Shakthi M Nagappan and Telangana Lifesciences for spotlighting innovation in life sciences. More moments from the event and our recognition coming soon — stay tuned! ?? Kolli Sarath | Paritosh Prashar #BioAsia2025 #CatalystsOfChange #LifeSciencesSummit #GlobalHealthcare #AIDrugDiscovery #BoltzmannLabs

?? Boltzmann Labs at BioAsia 2025 — Let’s shape the future of AI in life sciences! We’re thrilled to announce our participation at BioAsia 2025 — a global stage for innovation at the intersection of healthcare, biotechnology, and AI. Join us at Stall P25 to explore how Boltzmann Labs is pushing the boundaries of drug discovery and clinical research with AI-powered solutions: ? BOLTCHEM — AI chemistry studio for cutting-edge drug design ?? REBOLT — AI-assisted synthesis planning for smarter chemistry ?? BOLTPRO — AI-driven protein engineering for novel therapeutics ?? CLINBOLT — Revolutionizing clinical trials with AI intelligence Let’s connect, collaborate, and reimagine what’s possible with #GenerativeAI in life sciences and clinical research. We look forward to insightful conversations and building impactful partnerships. #BioAsia2025 #BoltzmannLabs #AIinLifeSciences #DrugDiscovery #ClinicalTrials #HealthcareInnovation #GenerativeAI

Forecast Progression & Empower Clinical Decisions with #DigitalTwins! In the evolving world of healthcare, precision is everything. Key Benefits: ?? Forecast Progression: Build tailored disease models to predict outcomes with remarkable accuracy. ?? Actionable Insights: Equip clinicians with data-driven, personalized insights, enabling them to make informed decisions that enhance patient care. With GenAI, precision and personalized care are within reach. ?? Write to us at [email protected] for collaborations on such projects! #GenAI #PersonalizedMedicine #HealthcareInnovation #PatientCare #DataDriven #ClinicalDecisions #DiseaseModeling #FutureOfMedicine

?? Streamline Protocol Creation with GenAI Precision In the fast-paced world of research and clinical trials, protocol development is key to success. With GenAI technology, we can now automate this process with unmatched precision!? ? Streamline Creation: Automate protocol development, saving time and boosting efficiency ? Ensure Compliance: Reduce errors and ensure full regulatory compliance every step of the way ?? Embrace the future of protocol authoring with GenAI – where speed, accuracy, and compliance come together! #GenAI #ProtocolAuthoring #Innovation #Compliance #Automation #ClinicalTrials #ResearchExcellence #FutureOfWork

?? Site Selection in Clinical Trials: A Crucial Factor for Successful Medical Innovation ?? Clinical trials are the driving force behind medical advancements, and choosing the right trial site is crucial to their success. In our latest blog post, we explore the vital role of site selection in clinical trials, highlighting key factors that influence the process, as well as emerging trends. Join us as we dive into the essentials and share real-world insights on how the right site can shape the future of medical research! ???? ?? Write to us at [email protected] #ClinicalTrials #SiteSelection #MedicalInnovation #DecentralizedTrials #Healthcare #ClinicalResearch #SCOPE #SCOPE2025